Event category: Concurrent Session

Events

September 04, 2025

2025-09-04

04:30 PM (EST) - 05:15 PM (EST)

Innovation Stage

Dhanunjaya R. Lakkireddy | Ilyas Colombowala | Hawkins Gay | Michael Katz | Joshua Lampert

From dictation software to full-blown natural language processing assistants, AI-based documentation tools promise to free clinicians from the tedium of charting. Physician burnout is on the rise—can AI-driven documentation help turn the tide? Strategies for successful change management, physician buy-in, and ongoing system optimization will be highlighted. How do we ensure data accuracy, privacy, and seamless integration into diverse electronic health records? Panelists will discuss the practical implementation of AI-assisted documentation and patient communication, while maintaining patient-centered care.

Ilyas Colombowala

Chief Medical and Compliance Officer

Octagos

Hawkins Gay

Clinical Electrophysiologist

Northwestern Medicine and the Feinberg School of Medicine

Michael Katz

Clinical Cardiac Electrophysiologist

Gagnon Cardiovascular Institute at Morristown Medical Center

Joshua Lampert

Cardiac Electrophysiologist & Medical Director of Machine Learning

Mount Sinai Heart in The Mount Sinai Hospital

Dhanunjaya R. Lakkireddy

Executive Medical Director of the Kansas City Heart Rhythm Institute

HCA Midwest in Overland Park, Kansas

2025-09-04

03:45 PM (EST) - 04:30 PM (EST)

Main Stage 2

Dominic Abrams | Vassilios Bezzerides | Gabriel Brooks | Samuel Hall | Andrew Krahn | Cain McClary | David Milan

Inherited arrhythmia syndromes and cardiomyopathies pose a significant clinic challenge, with suboptimal treatment and a large unmet need. Over the last decade several new therapies have been developed which target the underlying genetic and molecular causes of these conditions, and many are progressing from pre-clinical research to clinical trials. These discoveries offer a potential paradigm shift in treatment strategies and quality of life for patients. This panel focused on novel genetic and molecular therapies for inherited arrhythmia syndromes and arrhythmogenic cardiomyopathies will bring together experts with a broad range of experience including venture capital, clinicians, translational scientists, and biotech. The session will address a wide range of topics from lab discovery to commercialization.

Vassilios Bezzerides

Assistant Professor of Pediatrics

Boston Children's Hospital

Gabriel Brooks

Chief Medical Office

Solid Biosciences

Samuel Hall

Founder & Managing Partner

Scion

Andrew Krahn

Professor of Medicine

University of British Columbia

Cain McClary

Founder & Managing Partner

KdT Ventures

David Milan

Chief Scientific Officer

Leducq Corp

Dominic Abrams

Co-Director of the Center for Cardiovascular Genetics

Boston Children’s Hospital

2025-09-04

02:45 PM (EST) - 03:30 PM (EST)

Main Stage 2

Brynn Dechert-Crooks | Benjamin Hale | Jamie Harris | Lisa Roelle | John Triedman | Nicholas Von Bergen

From life-changing interventions to emotional uncertainties, how does cardiac technology shape the journey of children and young adults with arrhythmias? This session explores the evolving role of electrophysiology (EP) in pediatrics, the impact of cutting-edge devices, and the patient experience—balancing fear, hope, and the promise of innovation. Are we maximizing technology’s potential, or is is there more to uncover in improving outcomes and quality of life for young patients?

Benjamin Hale

Pediatric and Congenital Electrophysiologist

University of Iowa

Jamie Harris

Nurse Practitioner

Boston Children's Hospital

Lisa Roelle

Pediatric Electrophysiology Physician Assistant

Washington University in St. Louis & St. Louis Children's Hospital

John Triedman

Professor of Pediatrics | Former Chief of Pediatric EP

Harvard Medical School | Boston Children's Hospital

Nicholas Von Bergen

Professor of Pediatrics in Pediatric Cardiac Electrophysiologist | Co-Founder

University of Wisconsin-Madison | Atrility Medical, LLC

Brynn Dechert-Crooks

Pediatric Electrophysiology Nurse Practitioner

University of Michigan Congenital Heart Center

2025-09-04

02:00 PM (EST) - 02:45 PM (EST)

Main Stage 2

Mintu Turakhia | Shih-An Chen | Maulik Majmudar | Nagesh Rangappan | Venk Varadan | Jeffrey Wessler

This session explores how AI-driven innovations are transforming atrial fibrillation (AF) management, from prevention to long-term care. Experts will discuss AI-powered digital education, solutions for early intervention, and technology’s role in addressing key risk factors like obesity, sleep apnea, and exercise. Is AI the game-changer in achieving sustainable AF care, or just another trend? Join us to find out.

Shih-An Chen, MD

Professor of Medicine

National Yang Ming Chao Tung University

Maulik Majmudar

Chief Medical Officer and Co-Founder

Biofourmis

Nagesh Rangappan

CEO

PreMedAI Labs P Ltd.

Venk Varadan

Co-founder and CEO of Nanowear

Nanowear

Jeffrey Wessler

Cardiologist, Founder & CEO

Heartbeat Health

Mintu Turakhia

Chief Medical and Scientific Officer + EVP, Product Management and Innovation | Professor of Medicine and Cardiac Electrophysiologist

iRhythm Technologies, Inc. | Stanford University